86 studies found for:    immune thrombocytopenia OR immune thrombocytopenic purpura OR idiopathic thrombocytopenic purpura | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
immune thrombocytopenia OR immune thrombocytopenic purpura OR idiopathic thrombocytopenic purpura | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Rifaximin for Chronic Immune Activation in People With HIV
Condition: HIV
Intervention: Drug: Rifaximin/ Placebo
2 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
Intervention:
3 Recruiting Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Conditions: Type 2 Diabetes;   Metabolic Syndrome
Intervention: Other: water, glucose with or without amino acid
4 Recruiting Chronic Pain Risk Associated With Menstrual Period Pain
Conditions: Cystitis, Interstitial;   Dysmenorrhea;   Migraine Disorders;   Pelvic Pain;   Endometriosis;   Visceral Pain
Intervention: Drug: microgestin 1/20
5 Recruiting Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens
Condition: Normal Neutrophil Function
Intervention:
6 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
7 Recruiting Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
Condition: Circadian Dysregulation
Intervention: Behavioral: Meal schedule
8 Recruiting Effect of Dietary Habits on Metabolic Health
Conditions: Overweight;   Obesity;   Prediabetes;   Meals
Intervention: Behavioral: Meal schedule
9 Unknown  Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Conditions: Obesity;   Glucose Intolerance;   Diabetes;   Acanthosis Nigricans
Intervention:
10 Recruiting Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria
Condition: Cystinuria
Intervention: Drug: CBTD 0-3 gm
11 Unknown  Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
Conditions: Chronic Kidney Disease;   End-Stage Renal Disease
Interventions: Other: Medication Information Transfer Intervention;   Other: Usual care for hospital discharge
12 Recruiting Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Bevacizumab;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
13 Recruiting Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Conditions: Adult Solid Neoplasm;   Metastatic Melanoma;   Metastatic Renal Cell Cancer;   Recurrent Colorectal Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Ovarian Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Biological: Ziv-Aflibercept
14 Recruiting Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Condition: Malignant Mesothelioma
Interventions: Drug: pemetrexed disodium;   Other: clinical observation
15 Not yet recruiting Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma of the Skin;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Quality-of-Life Assessment;   Biological: Sargramostim
16 Recruiting Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: decitabine
17 Unknown  Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia;   Lymphoma
Intervention: Other: biologic sample preservation procedure
18 Not yet recruiting Diuretic Comparison Project
Condition: Hypertension
Interventions: Drug: Hydrochlorothiazide;   Drug: Chlorthalidone
19 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate
20 Recruiting Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: pemetrexed disodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years